双重单一疗法耐药慢性糖尿病黄斑的结合性肠内类固醇和抗VEGF疗法
Ophthalmic surgery, lasers & imaging retina
|September 25, 2025
概括
这项研究表明,结合长效皮质类固醇和抗血管内皮生长因子 (抗VEGF) 药物,可以有效治疗耐单一治疗的糖尿病黄斑 (DME). 组合疗法改善了视力,减少了视网膜厚度,没有安全问题.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病黄斑 (DME) 是糖尿病患者视力丧失的主要原因.
- 抗性DME往往需要超越标准单疗的先进治疗策略.
研究的目的:
- 为了评估联合内长效皮质类固醇和抗血管内皮细胞生长因子 (抗VEGF) 药物的疗效和安全性.
- 评估糖尿病黄斑 (DME) 的治疗结果,这些没有对单一治疗产生反应.
主要方法:
- 从15名患有治疗耐药性DME的患者的16只眼睛的回顾性图表审查.
- 同时对抗VEGF和脱的三诺进行内注射.
- 光学连贯断层扫描 (OCT) 和眼科检查评估了4个月的视网膜中心厚度 (CRT) 和最佳校正视敏度 (BCVA).
主要成果:
- 治疗后1,2,3个月观察到视网膜中心厚度 (CRT) 的显著减少 (P <0.05).
- 最好的校正视敏度 (BCVA) 在1个月后平均提高了8.5个字母,并持续了3个月 (P <0.05).
- 在组合治疗中没有报告眼部或全身安全问题.
结论:
- 联合内类固醇和抗VEGF疗法显示,具有对单一治疗耐药的DME眼睛的显著解剖和功能改善.
- 这种组合方法为耐治疗的糖尿病黄斑提供了治疗效果.
相关概念视频
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K


